Anbio Biotechnology

NNNN ·Healthcare, Drug Manufacturers - General, Germany
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $15.8M

Liabilities Breakdown FY2023

Total Liabilities: $993.1K